NF-κB inhibition prevents acute shear stress-induced inflammation in the saphenous vein graft endothelium by Ward, A.O. et al.
This is a repository copy of NF-κB inhibition prevents acute shear stress-induced 
inflammation in the saphenous vein graft endothelium.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/166177/
Version: Published Version
Article:
Ward, A.O., Angelini, G.D., Caputo, M. et al. (6 more authors) (2020) NF-κB inhibition 
prevents acute shear stress-induced inflammation in the saphenous vein graft 
endothelium. Scientific Reports, 10 (1). 15133. ISSN 2045-2322 
https://doi.org/10.1038/s41598-020-71781-6
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
 ?
Ǥǣȋ ? 洃渃? ? 焃? ? ? ?Ȍ
SCIENTIFIC REPORTS |        (2020) 10:15133  | ǣȀȀǤȀ ? ?Ǥ ? ? ? ?Ȁ ? ? ? ? ?Ǧ ? ? ?Ǧ ? ? ? ? ?Ǧ ?
www.nature.com/scientificreports
	ǦɈ
Ǧƪ


Ǥ ?ǡ
Ǥ ?ǡ ?ǡǤ ?, 
Ǥ ?ǡǤ ?ǡǤ ?ǡǤ
 ?ǡ ? & 
 ?ǡ ?*
ȋȌǤ
ǡƪǡ
Ǥ
ȋȌȋȌǡ
ƪǡƤǤǡ
ƪ
	ǦɈǦǦǤ
	ǦɈ ? ?Ǥ
	ǦɈ ?
 ?Ǥǡ
Ǥ	ǦɈ
Ǧ ?ǡ
,
ǦǦƪǤƤ	ǦɈ
ƪǤ
ǦƤ	ǦɈƤ
ƪǤ
Abbreviations
CABG  Coronary artery bypass grating
IH  Intimal hyperplasia
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NF-κB  Nuclear factor-κB
VEC  Venous endothelial cells
LSV  Long saphenous vein
CCL2  Monocyte chemoattractant protein 1
HUVEC  Human umbilical vein endothelial cells
IL-6  Interleukin-6
IL-8  Interleukin-8
ICAM-1  Intercellular adhesion molecule 1
Ischaemic heart disease (IHD) is one of the leading causes of mortality in the UK and  worldwide1. Coronary 
artery bypass grating (CABG) remains the gold standard intervention in the presence of complex coronary 
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disease, diabetes and poor ventricular  function2–6. he long saphenous vein (LSV) is the most used conduit in 
many  patients7,8, however, its use is complicated by considerable rates of late stenosis or occlusion due to the 
development of intimal hyperplasia (IH) and superimposed  atherosclerosis9. IH is a chronic inlammatory 
process that starts with endothelial cell (EC) activation, followed by the migration and proliferation of smooth 
muscle cells (SMC) to the intima, which is then accompanied by alterations in extracellular  matrix10 (ECM). 
Vascular inlammation is regulated by signalling intermediaries, including Nuclear Factor-κB, NF-κB (p65), 
that trigger EC expression of chemokines such as monocyte chemotactic protein-1 (CCL2) and other pro-
inlammatory molecules.
he susceptibility of vessels to inlammatory processes may, in part, be related to the vascular bed from which 
they originate and the types of haemodynamic environment to which they are chronically  exposed11. Venous ECs 
in situ, are adapted to chronic levels of low shear stress and, following grating, they become exposed to shear 
stresses (deined as force/wall area and measured in dyn/cm2) up to tenfold higher in the arterial  system12. Acute 
onset of increased rates of shear stress is known to alter the phenotype of venous EC; however, the mechanisms 
that underpin this response have not been fully elucidated. To gain better insight into the intrinsic molecular 
mechanisms underlying pro-inlammatory responses of veins to grating, we investigated the impact of acute 
shear changes on NF-κB activation and associated vECs response in vitro, ex vivo and in vivo.

ǦƪǤ Freshly harvested 
segments of human LSV were acutely exposed to arterial shear stress, ex vivo, at 12 dyn/cm2, a rate which has pre-
viously been associated with EC activation and vascular remodelling in ex vivo venous bypass grat  models12,13. 
We noted a signiicant increase in CCL2 mRNA levels in LSV ECs following exposure to acute high shear stress 
(acute arterial WSS) (Fig. 1A). En face immunoluorescent staining revealed that exposure of veins to acute arte-
rial WSS increased CCL2 expression in ECs at the protein level (Fig. 1B,C and Supplementary videos 2 and 3).
	ǦɈ    Ǧƪ       
Ǥ To investigate the possible role of NF-κB, we analysed the expression of p65 NF-kB sub-units 
in LSVs exposed to arterial shear stress. acute arterial WSS enhanced p65 nuclear translocation in ECs (Fig. 1D,E 
and Supplementary video 1), indicating that acute arterial shear stress activates NF-kB in LSV endothelium. To 
investigate the function of NF-κB on pro-inlammatory responses to acute arterial WSS, a selective small-mol-
ecule NF-kB inhibitor, BAY11-7085 (BAY) was used (Supplementary Figure 9). he pre-treatment of LSV with 
50 µmol/L of BAY modulated EC responses to acute arterial WSS by reducing the levels of CCL2 (Fig. 2A,B). 
Furthermore, NF-κB inhibition reduced acute arterial WSS induced monocyte adhesion to the LSV endothe-
lium (Fig. 2C,D). hus, we conclude that NF-κB inhibition can suppress the initiation of monocyte adhesion to 
ECs in veins under acute arterial WSS.
   Ǧƪ    	ǦɈ  
Ǥ To validate our ex vivo indings and further investigate the molecular basis involved in the venous 
EC response to arterial rates of shear stress, we studied the efects of acute arterial WSS on HUVECs in vitro. 
Acute high shear stress signiicantly increased nuclear translocation of p65 (Fig. 3A,D) which was associated 
with reciprocally decreased IκBα expression (Fig. 3B,D) indicating the activation of the NF-κB classical pathway. 
Furthermore, NF-κB was phosphorylated at Serine residue 276 (Ser-276) following 30 min of acute arterial WSS 
(Fig.  3C,D), whilst also showing increased DNA binding to the NF-κB consensus oligonucleotide (Fig.  3E), 
both of which are indicative of transcriptional activation of NF-κB. his transcriptional activation was transient, 
with levels peaking at 30 min, which is likely indicative of the feed-forward mechanism of negative regulation 
of NF-κB by IκBα following 60 min acute arterial WSS  exposure13. We observed that acute arterial WSS, but 
not low shear, was associated with up regulation of CCL2 (Fig. 4A–D). he suppression of the NF-κB classical 
pathway using 20 μmol/L BAY pre-treatment resulted in reduced pro-inlammatory activation, similar to what 
was observed ex vivo (Fig. 5A).
We further validated these indings using adenoviral-mediated over-expression of WT-IκBα (Supplementary 
Figure 9), which demonstrated that the overexpression of WT-IκBα prevented induction of CCL2 following 
exposure to acute arterial WSS (Fig. 5B). Moreover, immunoanalysis showed a signiicant reduction in the 
expression of CCL2 following 4 h of acute arterial WSS, as compared with static controls (Fig. 5C,D). Whilst, 
overexpression of WT-IκBα prevented the loss of VE-Cadherin cell–cell contacts following acute arterial WSS 
exposure (Fig. 5E,F), indicative of an intact endothelial barrier.
We next looked at the impact of NF-κB inhibition on monocyte-EC interactions in vitro, dynamically and in 
real-time, following exposure to acute arterial WSS. We noted that the pre-treatment of HUVECs with 20 μmol/L 
BAY signiicantly reduced acute arterial WSS-induced dynamic monocyte adhesion to the vEC monolayer 
(Fig. 5G,H).
	ǦɈǦǤ Having 
observed a signiicant increase in CCL2 mRNA and protein in the LSV endothelium, we then analysed a publicly 
available gene expression microarray dataset, generated from a rabbit bilateral interposition vein grat  model14. 
Grats were maintained under low or high shear stress, for 2 and 24 h each. Log expression values (Log Fold 
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Change (LogFC)) of diferentially expressed genes (1602 genes) signiicantly diferent (p < 0.01) from baseline, 
in any of the 4 grat conditions were hierarchically clustered and plotted (Supplementary Figure 8A). Interest-
ingly, gene set enrichment analysis between the two acute groups (high and low shear) revealed highly sig-
niicant enrichment of biological process GO-terms involved in the inlammatory response, cytokine-mediated 
signalling and neutrophil activity, in grats exposed to high shear, but not low (Supplementary Figure 8B,C). In 
addition, the high shear-exposed grats showed the least overlap with any other grat condition, in terms of both 
gene overlap and GO-terms, suggesting that grats exposed to high shear had the largest functionally unique 
change of any other condition (Supplementary Figure 8D,E). Within grats exposed to high shear stress for 2 h, 
signiicantly up-regulated genes with a LogFC > 1.5 (a total of 114 genes) were analysed further for functional 
pathway and motif enrichment. Transcriptional regulatory inference, performed using  LISA15, ranked NF-κB as 
Figure 1.  Activation of the LSV endothelium by acute arterial wall shear stress. he LSV endothelium was 
activated following exposure to acute arterial rates of shear stress, shown by NF-κB translocation and increased 
CCL2 protein levels. LSV sections were exposed to acute arterial WSS at 12 dyn/cm2 for 30 and 90 min or 
maintained in static conditions and immunostained en face for the localisation of NF-κB in LSV ECs. (A) LSV 
portions were exposed to acute arterial WSS for 90 and 120 min or maintained in static conditions, following 
shear exposure EC RNA was extracted and mRNA levels of pro-inlammatory genes (CCL2, IL-6, IL-8 and 
ICAM-1) were evaluated by RT-qPCR. Data shown represents independent experiments with 4 diferent 
segments of LSV. (B) Mean arbitrary luorescence intensity of CCL2 immunostaining calculated using FIJI. 
(C) Representative images of independent experiments with 3 diferent segments of LSV, white arrows indicate 
perinuclear localisation of CCL2 and scale bar represents 10 µm. (D) Mean arbitrary luorescence intensity of 
NF-κB en face immunostaining in endothelial nuclei 3D volumes shown for all 3 conditions, as calculated by 
Imaris. (E) Representative images of independent experiments with 5 diferent segments of LSV immunostained 
en face for the quantiication of nuclear NF-κB, scale bar represents 10 µm. Two-tailed two-sample t-test (B) 
and One-way ANOVA followed by post-hoc pairwise comparisons with Bonferroni correction (D) were used to 
calculate signiicance, where, **** indicates p < 0.0001, ** indicates p < 0.01 and * indicates p < 0.05.
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the most probable transcriptional regulator of this gene-set, which was further supported by the observation that 
the NF-κB motif was highly enriched within the promoter regions of these genes (Supplementary Figure 8F,G). 
Finally, KEGG and REACTOME pathway analysis revealed that this gene list was strongly associated with the 
TNFα- and NF-kappaB signalling pathways, further supporting the role for NF-κB activation in vein grats fol-
lowing acute shear stress exposure (Supplementary Figure 8H).

Vein grat disease following CABG remains a problem of serious clinical signiicance despite decades of surgical 
 advances16,17. Haemodynamics inluence the inlammatory process by controlling leukocyte margination and 
adhesive interactions and by generating shear stress, which in turn alters EC  physiology18,19. Increased shear 
stress rates in the LSV grat have long been considered to directly afect grat patency and survival; however, at 
present, there is no clinical consensus as to the extent of this efect, perhaps due to the diverse range of rates of 
grat WSS exposure,  postoperatively20,21. Furthermore, the molecular cascades that occur ater acute increases in 
WSS rates in LSV grat ECs remain poorly understood. We, and others, have previously shown that arterial and 
venous EC respond diferently to acute high shear stress, in both in vivo and ex vivo grat  models13,22–24. Here, 
we show that the NF-κB classical pathway is activated in the endothelium of LSV in response to acute exposure 
to arterial rates of shear stress and is a critical regulator of vascular inlammation in veins. In vitro experiments 
further demonstrated that targeting NF-κB prior to acute low induction was suicient to prevent endothelial 
CCL2 expression and monocyte recruitment, as well as EC cell–cell contact disruption, another hallmark of the 
dysfunctional endothelium.
hese indings in the LSV were further substantiated by evidence from analysis of a previously  published14 
in vivo rabbit vein grat model and DNA microarray. Diferential expression analysis revealed signiicantly 
Figure 2.  Inhibition of NF-κB and endothelial pro-inlammatory response to acute high shear stress—ex vivo. 
Inhibition of NF-κB prevented the pro-inlammatory response associated with acute arterial WSS in LSV ECs 
ex vivo. (A) Segments of LSV were incubated for 3 h with 50 µmol/L NF-κB inhibitor, BAY11-7085, or 0.5% 
(v/v) DMSO control and were then exposed to acute arterial WSS for 6 h, or maintained in static conditions. 
Segments were then immunostained en face for the quantiication of CCL2 in LSV ECs. (A) Mean arbitrary 
luorescence intensity of CCL2 immunostaining calculated using FIJI. (B) Representative images of independent 
experiments with 4 diferent segments of LSV, white arrows indicate perinuclear localisation of CCL2 and scale 
bar represents 10 µm. Sections of LSV were exposed pre-treated for 3 h with 50 µM NF-κB inhibitor, BAY11-
7085, or 0.5% (v/v) DMSO control and were then exposed to acute arterial WSS for 6 h. Following acute arterial 
WSS exposure, LSV sections were immediately prepared en face and incubated with 1 × 106 Calcein-labelled 
monocytes per mL for 15 min then imaged immediately. (C) Total number of monocytes was calculated using 
CellProiler sotware. (D) Images represent independent experiments with 4 diferent segments of LSV and scale 
bar represents 50 µm. Two-way ANOVA followed by post-hoc pairwise comparisons with Bonferroni correction 
(A,C) was used to calculate signiicance, where, * indicates p < 0.05.
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up-regulated NF-κB and inlammatory pathway-related genes between acute high and low shear-exposed vein 
grats. Together, these data provide a possible mechanism for the regulation of acute vein grat inlammation, 
a factor which is inextricably linked to downstream pathologies. Furthermore, owing to the unique window of 
opportunity to locally pre-treat the autologous vein grat prior to implantation, inhibition of NF-κB may represent 
an exciting possibility in the resolution of vascular inlammation within the grat.
Acute onset of increased rates of shear stress is known to promote inlammatory transcriptional responses in 
ECs in vitro, a process mediated through NF-κB, p38-MAPK and activating protein 1 (AP-1)17,24–27. However, 
no studies so far have directly addressed the role of acute shear stress on NF-κB pathway activation in the vein 
grat endothelium.
Our indings with regards to activation of CCL2 are in concordance with previously published small animal 
in vivo  data28,29. Several previous studies have shown that in vivo, local NF-κB inhibition, using either a decoy 
cis-element (κB-oligodeoxynucleotide), siRNA-mediated knockdown or an alternate gene therapy approach to 
overexpress IκBα, limits IH development in multiple vein grat  models30–32. However, all such previous models 
propose the same conclusions for their observed results; that it is due to the actions of NF-κB inhibition on reduc-
tion of medial VSMC proliferation and migration, and not the role of NF-κB in the acute adaptive response of the 
vein grat to its new haemodynamic environment. Following this acute haemodynamic adaptation, ECs typically 
Figure 3.  Acute high shear stress and activation of the NF-κB classical pathway—in vitro. he NF-κB classical 
pathway was activated under acute high shear stress as indicated irstly by the nuclear translocation of NF-κB 
and reciprocal reduction in cytosolic levels of IκBី, as well as phosphorylation and increased DNA binding 
ainity. HUVECs were exposed to acute arterial WSS for 30 and 90 min or maintained in static conditions, then 
cellular fractions were collected to be analysed by Western blotting. Total amounts of protein were quantiied 
relative to stain-free loading controls and expressed as a fold change of static control. (A) Nuclear NF-κB, (B) 
cytosolic levels of IκBី and (C) Phospho-NF-κB (Serine residue 276 (Ser276)) from whole cell lysates were 
analysed by WB, and normalised to stain-free loading controls from nuclear, cytosolic and whole cell lysates, 
respectively. Western blots shown are representative of 5 or 6 independent experiments showing, in addition 
to NF-κB and IκBី, markers of nuclear and cytosolic fractions, Lamin A/C and GAPDH respectively (D). 
he transcriptional activation of NF-κB under acute arterial WSS, for both 30 and 90 min, was assessed by 
phosphorylation at Serine residue 276 (C) and DNA binding activity (E) in whole cell lysates. ELISA based 
DNA binding activity assay was performed using total cell lysates and was expressed relative to static controls 
and were representative of 3 independent experiments. One-way ANOVA followed by post-hoc pairwise 
comparisons with Bonferroni correction was used to calculate signiicance, where, ** indicates p < 0.01 and * 
indicates p < 0.05.
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promote endogenous mediators that promote quiescence and dampen inlammation, through the activation of 
KLF2 and Nrf2 and repression of NF-κB, within 12 h of high WSS  exposure33. Our novel indings demonstrate 
a potential role of acute NF-κB inhibition in maintaining this quiescent, anti-inlammatory endothelium prior 
to and under conditions of arteriovenous transposition that may further help to ameliorate the pathogenic 
progression to late-stage grat failure.
In conclusion, we identiied that acute arterial WSS is responsible for early pro-inlammatory activation of the 
LVG EC, a process regulated by NF-κB (p65) activation, resulting in upregulation of pro-inlammatory media-
tors and increased monocyte recruitment, thus, providing the irst evidence for the mechanistic involvement of 
NF-κB in shear-induced inlammation in the vein grat endothelium.

Detailed descriptions of all materials and methods can be found in the Supplementary Methods.
Ǥ he study was approved by the NRES Committee East of England—Norfolk 
ethics number (REC14/EE/1097) and all use of human tissue conformed to the principles outlined in the Decla-
ration of Helsinki. Surplus segments of surgically prepared human long saphenous vein (LSV), resected during 
Figure 4.  NF-κB target gene response to acute high shear stress—in vitro. Pro-inlammatory, NF-κB target 
genes were increased in ECs exposed to acute arterial WSS, in vitro. (C,D) HUVECs were exposed to AASS at 
12 dyn/cm2 (A) and acute low shear stress (ALSS) at 0.5 dyn/cm2 (B) for 90 and 120 min in order to compare 
pro-inlammatory gene transcript levels by RT-qPCR. Data represent 6 independent experiments. (C,D) 
HUVECs were exposed to AASS at 12 dyn/cm2 for 4 h or maintained in static conditions, then immunostained 
for quantiication of total CCL2 using CellProiler. (C) Mean arbitrary luorescence intensity of CCL2 staining 
was evaluated in whole cells. (D) Images are representative of 3 independent experiments and scale bar 
represents 15 µm. One-way ANOVA followed by post-hoc pairwise comparisons with Bonferroni correction 
(A,B) and two-tailed two-sample t-test (C) were used to calculate signiicance, where, * indicates p < 0.05.
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coronary artery bypass grat surgery, from anonymised consenting patients, were exposed to acute arterial WSS, 
at 12 ± 0.2 dyn/cm2, for between 30 min to 6 h using an in-house designed bioreactor system.
En face Ǥ Briely, segments of LSV were assessed for the cellular localisation of NF-κB 
and quantity of CCL2 ater exposure to acute arterial WSS by immunostaining of en face prepared vessels (for 
detailed description, see Supplementary Methods). he LSV endothelium was imaged en face, using confocal 
microscopy (Leica, Germany) and image analysis was all performed in 3D, either using Imaris (Supplementary 
Figure 3) or ImageJ (Supplementary Figure 4).
Ǥ Following a 3-h incubation with 50 µmol/L NF-κB inhibitor, BAY11-7085, 
and exposure to acute arterial WSS for 6 h, LSV segments were dissected longitudinally, pinned with the lumi-
nal surface facing upwards and co-cultured, in static conditions, with 1 × 106 Calcein AM-labelled (10 µmol/L) 
THP-1 cells for 15 min. Immediately ater co-culture and washing, in situ adhered monocytes and LSV segments 
were imaged using luorescence microscopy (Zeiss, Germany).
Ǥ For extraction of RNA from LSV ECs, a technique was used which involves the 
lushing of the lumen of the vessel with a severe lysis bufer, in this case, Qiazol (Qiagen), to disrupt cells in the 
intimal layer, which were predominantly  ECs34. Briely, segments were cut transversely into 2–3 cm lengths and 
washed in ice-cold DPBS. Using a 1 mL syringe and 18-gauge unbevelled needle with the tip inserted a into the 
vessel lumen, the vessel was lushed with ice-cold DPBS. Finally, the lumen was quickly lushed (3–6 s) with 350 
μL of ice-cold Qiazol and the eluate was collected in a 1.5 mL Eppendorf tube. his eluate was subjected to the 
RNA isolation protocol described later.
Ǥ HUVECs were exposed to laminar, unidirectional shear stress (at 0.5 or 12 
dyn/cm2 to simulate venous and arterial rates of shear stress, respectively) for varying times, using parallel plate 
low chambers designed in-house (Supplementary Figure 2), as described  previously35, or maintained in static 
conditions. Following HUVEC dynamic culture for variable time-points, cells were subjected to analysis for 
immunocytochemistry, qPCR or Western Blotting.
ǦǤ HUVECs were exposed to acute arterial WSS using the micro-
luidic capillary Biolux 200 system, which allowed for dynamic co-culture with THP-1 cells and visualisation in 
real-time (Supplementary video 4). Briely, following a 3 h incubation with 20 µmol/L NF-κB inhibitor, BAY11-
7085, CmDiI-labelled HUVECs were exposed to acute arterial WSS at 12 dyn/cm2 for 4 h, ater which point, 
Calcein-labelled THP-1 cells were introduced into the system and co-cultured, under shear stress (at 1 dyn/
cm2), for a further 10 min, and imaged in real time (for detailed description, see Supplementary methods). Total 
number of adhered monocytes were then enumerated.
Ǥ Briely, HUVECs cultured on glass slides and subsequently exposed to shear 
stress, or maintained in static conditions, were ixed in 3% Paraformaldehyde (PFA). Following ixation, 
HUVECs were stained with primary antibodies against either NF-κB, CCL2 or VE-Cadherin, followed by appro-
priate secondary antibodies. Slides were then imaged using the Zeiss AxioObserver Z1 luorescent microscope 
and automated quantiication was performed with CellProiler analysis sotware (for detailed description, see 
supplementary methods).
	ǦɈǤ Total HUVEC lysates were used to detect NF-κB binding activity using a TransAM 
p65 DNA-binding ELISA kit (Active Motif, USA). he manufacturer’s instructions were followed and the col-
ourimetric reaction endpoint was read at 450 nm.
 Ǥ For experiments where only two groups were analysed, data were subjected to 
a paired, two- tailed t-test. For experiments where more than two groups were analysed, a one- or two-way 
ANOVA was used depending on the number of independent variables, followed by post-hoc pairwise compari-
sons with Bonferroni correction for multiple comparisons. If datasets were large enough (for example for immo-
cytochemical analyses, where 20 images per sample were analysed), normal distribution was assessed with the 
D’Agostino-Pearson test; all data assessed passed normality tests, as such, parametric analyses were appropriate. 
he cut-of value for statistical signiicance was 0.05. Data are presented as mean ± SEM. All statistical analysis 
was performed with GraphPad Prism 7.0.
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